Private Foundation

S A S FOUNDATION FOR CANCER RESEARCH INC

S A S FOUNDATION FOR CANCER RESEARCH INC is a Private Foundation headquartered in BIBLE SCHOOL PARK, NY. Financial data from the 2024 filing: $83K revenue, $124K expenses, $1.3M total assets. IRS filings disclose 12 grants awarded by this foundation, totaling roughly $532K.

EIN: 352318752 BIBLE SCHOOL PARK, NY Latest filing: 2024
Total Revenue$83K
Total Expenses$124K
Total Assets$1.3M
Grants Given12
Grant Total$532K
Filing Years2019–2024

Sample Grants Given

ROSWELL PARK ALLIANCE FOUNDATION
BUFFALO, NY · 2024
DECIPHERING THE DRUG RESISTANCE MECHANISM OF TRIPLE-NEGATIVE BREAST CANCER AGAINST DOXOCRUBICIN BY PROTEOME-WIDE OVEREXPRESSION PERTURBATION
$28,225
ROSWELL PARK ALLIANCE FOUNDATION
BUFFALO, NY · 2023
DECIPHERING THE DRUG RESISTANCE MECHANISM OF TRIPLE-NEGATIVE BREAST CANCER AGAINST DOXOCRUBICIN BY PROTEOME-WIDE OVEREXPRESSION PERTURBATION
$71,775
ROSWELL PARK ALLIANCE FOUNDATION
BUFFALO, NY · 2023
EXPLORING THE ROLE OF HNF1A IN TUMOR GROWTH AND MICROENVIRONMENT DYNAMICS IN PANCREATIC DUCTAL ADENOCARNINOMA.
$63,554
ROSWELL PARK ALLIANCE FOUNDATION
BUFFALO, NY · 2023
comparison of intermittent fasting with continuous caloric reduction in black adults of faith
$10,291
LUSTGARTEN FOUNDATION
WOODBURY, NY · 2022
A TRANSLATIONAL CONVERGENCE PROGRAM OF PERSONALIZED IMMUNOTHERAPY FOR PANCREATIC CANCER PATIENTS AT JOHNS HOPKINS UNIVERSITY.
$50,000

Showing up to 5 of 12 total records — full history available with membership.

Officers & Directors

Vice President John Hrywnak
Treasurer Joshua Hrywnak
President & CEO Mary Ann Hrywnak

Officer compensation and complete director data available with membership.

Top Grant Purposes

Research regarding prevention of prostate cancer progression and therapy-induced muscle loss.
$128,693 2 grants
DECIPHERING THE DRUG RESISTANCE MECHANISM OF TRIPLE-NEGATIVE BREAST CANCER AGAINST DOXOCRUBICIN BY PROTEOME-WIDE OVEREXPRESSION PERTURBATION
$100,000 2 grants
EXPLORING THE ROLE OF HNF1A IN TUMOR GROWTH AND MICROENVIRONMENT DYNAMICS IN PANCREATIC DUCTAL ADENOCARNINOMA.
$100,000 2 grants
Research regarding targeting the PRMT5 Arginine Methyltransferase: an achilles' heel for many cancers.
$74,321 2 grants
Research regarding characterizing the role of Aquaporin-7 in the breast cancer metabolic landscape.
$50,000 1 grant

Financial Trends

Year Revenue Expenses Assets
2024 $83K $124K $1.3M
2023 $95K $248K $1.3M
2022 $37K $195K $1.3M
2020 $84K $89K $1.8M
2019 $77K $203K $1.7M

Between 2019 and 2024, reported annual revenue grew from $77K to $83K (+8%), with total assets most recently reported at $1.3M.

Interactive year-over-year charts and full filing details available with membership.

Grant Geography

Grants from this foundation were reported to recipients in IN, NY.

INNY

Full geographic grant map with state-by-state breakdown available with membership.

See the full picture for S A S FOUNDATION FOR CANCER RESEARCH INC

Complete financials, all 12 grant records, officer compensation, year-over-year trend charts, a geographic grant map, and data exports — across 498,000+ organizations.

Full Financial History Complete Grant Activity Officer Compensation Year-over-Year Charts Geographic Grant Map Data Exports
Start Free Trial → Log In
7-day free trial Cancel any time